Findings from Inflammatory Bowel Disease Center in the Area of Inflammatory Bowel Disease Reported (Utility of a Third Heplisav-b Dose In Patients With Inflammatory Bowel Disease Without Immunity After 2-dose Heplisav-b Vaccination)

Source :: Vaccine Weekly. November 20, 2024, 2099
Publication Year :: 2024
Abstract: 2024 NOV 20 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators publish new report on Digestive System Diseases and Conditions - Inflammatory Bowel Disease. According [...]

Subjects :: Takeda Pharmaceutical Company Ltd.
Heplisav-B (Medication) -- Research
Care and treatment
Research
Medical research
Vaccination -- Research
Gastrointestinal diseases -- Research -- Care and treatment
Hepatitis B -- Research -- Care and treatment
Pharmaceutical industry -- Research
Medicine, Experimental

Tools